Incyte CORP Form 4 insider transactions

Pablo J Cagnoni, President, Global Head of R&D of Incyte Corp, sold 10,803 shares of common stock on August 12, 2026 for $120.04 per share.

Pablo J Cagnoni, President, Global Head of R&D of Incyte Corp, sold 10,640 shares of common stock on August 5, 2026 for $122.69 per share.

Michael James Morrissey, EVP, Head of Tech. Operations of Incyte Corp, reported multiple transactions in common stock on July 23, 2026.

Lee Heeson, EVP, Head of Incyte Intl of Incyte Corp, reported multiple transactions in common stock on July 23, 2026.

Thomas Tray, Principal Accounting Officer of Incyte Corp, reported multiple transactions in common stock on July 16, 2026.

Steven H Stein, CMO & Head of Late-Stage Dev. of Incyte Corp, sold 1,877 shares of common stock on July 16, 2026 for $114.73 per share.

Patrick A Mayes, EVP & Chief Scientific Officer of Incyte Corp, reported multiple transactions in common stock on July 16, 2026.

Pablo J Cagnoni, President, Global Head of R&D of Incyte Corp, reported multiple transactions in common stock on July 16, 2026.

Mohamed Khairie Issa, EVP, Head of U.S. Commercial of Incyte Corp, sold 1,093 shares of common stock on July 16, 2026 for $115.01 per share.

Ramitpal K Basi, EVP, Human Resources of Incyte Corp, reported multiple transactions in common stock on July 16, 2026.

David H Gardner, EVP, Chief Strategy Officer of Incyte Corp, reported multiple transactions in common stock on July 16, 2026.

Richard A. Hoffman, EVP & General Counsel of Incyte Corp, reported multiple transactions in common stock on July 16, 2026.

William Meury, Chief Executive Officer and a Director of Incyte Corp, reported multiple transactions in common stock on July 16, 2026.

Pablo J Cagnoni, President, Global Head of R&D of Incyte Corp, reported multiple transactions in common stock on July 14, 2026.

Patrick A Mayes, EVP & Chief Scientific Officer of Incyte Corp, reported multiple transactions in common stock on July 14, 2026.

Thomas Tray, Principal Accounting Officer of Incyte Corp, reported multiple transactions in common stock on July 14, 2026.

Steven H Stein, CMO & Head of Late-Stage Dev. of Incyte Corp, sold 28,237 shares of common stock on July 14, 2026 for $113.05 per share.

Mohamed Khairie Issa, EVP, Head of U.S. Commercial of Incyte Corp, reported a transaction in 1,099 shares of common stock on July 15, 2026.

Incyte Corp executive Patrick Mayes reported a transaction involving the withholding of shares for tax obligations and disclosed remaining unvested restricted stock units.

Thomas Tray of Incyte Corp reported a transaction involving the sale of common stock.

Incyte Corporation executive William Meury has reported a transaction involving the withholding of shares to cover tax obligations and disclosed beneficial ownership of common stock and unvested equity awards.

Steven H. Stein, CMO & Head of Late-Stage Development at Incyte Corp, reported a transaction involving the sale of 2,177 shares of common stock.

Baker Bros. Advisors LP and affiliated entities reported transactions involving Incyte Corp common stock, including acquisitions and dispositions.

Paul J. Clancy, a Director at Incyte Corp, acquired 252 shares of common stock on June 30, 2026, as part of a compensation plan.

Baker Bros. Advisors LP and affiliated entities report transactions involving Incyte Corp common stock and stock options, including grants of restricted stock units and non-qualified stock options.

Incyte Corporation director Edmund Harrigan reported transactions involving restricted stock units and stock options.

Incyte Corp. Director Paul J. Clancy acquired 1,642 shares of common stock and exercised a stock option for 6,111 shares.

Incyte Corporation director Jacqualyn A. Fouse acquired restricted stock units and a stock option, as disclosed in a Form 4 filing.

Jean Jacques Bienaime, a Director at Incyte Corp, reported the acquisition of 1,642 shares of common stock and the grant of a non-qualified stock option for 6,111 shares.

Director Katherine A. High of Incyte Corporation has reported the acquisition of restricted stock units and the vesting of stock options.